Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Fred Poordad

1-50 of 75 results

View this query on the Wikidata Query Service
Boceprevir for previously treated chronic HCV genotype 1 infection

scientific article
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

scientific article published on 11 April 2014
Response-guided telaprevir combination treatment for hepatitis C virus infection

scientific article
Rifaximin treatment in hepatic encephalopathy

scientific article
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

scientific article
Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

scientific article published on 10 April 2014
Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

scientific article published in February 2010
Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article published on 4 June 2014
Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study

scientific article
Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C

scientific article published on January 3, 2013
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence

scientific article published on 11 January 2016
Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1

scientific article published on January 16, 2014
Thrombocytopenia associated with chronic liver disease

scientific article
Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial

scientific article published on November 2013
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection

scientific article
Factors that predict response of patients with hepatitis C virus infection to boceprevir

scientific article published on 21 May 2012
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis

scientific article published on 12 April 2017
Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis

scientific article published on May 5, 2015
Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks

scientific article published on October 22, 2015
Sofosbuvir with peginterferon‐ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis

scientific article published on January 30, 2015
Rapid virologic response: a new milestone in the management of chronic hepatitis C.

scientific article published on January 2008
Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA

scientific article published on January 23, 2014
Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment

scientific article published on 27 January 2017
A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care

scientific article
Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection

scientific article published on May 5, 2015
Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy

scientific article
High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis

scientific article published on 22 July 2016
Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection

scientific article published on October 10, 2012
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

scientific article published on 20 November 2017
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1

scientific article published on February 22, 2013
Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis

scientific article
Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies

scientific article published on July 19, 2013
Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients

scientific article published on 31 August 2007
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection

scientific article published on 30 July 2016
Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

scientific article published on 29 June 2012
Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients With Chronic Hepatitis C Virus Genotype 1 Infection—A Randomized Trial

scientific article published on August 4, 2013
Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study

scientific article published on April 27, 2013
Exploratory trial of ombitasvir and ABT-450/r with or without ribavirin for HCV genotype 1, 2, and 3 infection

scientific article published on September 22, 2014
Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response

scientific article published on December 19, 2013
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

scientific article published on 19 September 2017
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients

scientific article
Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial

scientific article
Comorbidities associated with the increasing burden of hepatitis C infection

scientific article published on 08 April 2010
Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials

scientific article
Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.

scientific article published on October 2010
Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral-experienced patients with genotype 1 hepatitis C virus

scientific article published on 21 February 2017
Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia

scientific article published on February 25, 2011
Emerging therapeutic options in hepatitis C virus infection

scientific article published on March 2011
Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia

scientific article published on September 6, 2015
Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patient

scientific article published on July 19, 2011

Paulina is supported by:

About Paulina

Help